| # | Drug | Count |
|---|---|---|
| 0 | PREDNISONE | 117 |
| 1 | DIPHENHYDRAMINE HYDROCHLORIDE | 110 |
| 2 | ADALIMUMAB | 106 |
| 3 | DUPILUMAB | 88 |
| 4 | OMALIZUMAB | 86 |
| 5 | ACETAMINOPHEN | 84 |
| 6 | LENALIDOMIDE | 80 |
| 7 | ETANERCEPT | 71 |
| 8 | METHOTREXATE SODIUM | 69 |
| 9 | GABAPENTIN | 63 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | DIPHENHYDRAMINE HCL AND ZINC ACETATE | 1 | 0.0455 |
| 1 | CAIRINA MOSCHATA HEART/LIVER AUTOLYSATE | 2 | 0.0417 |
| 2 | NEOMYCIN AND POLYMYXIN B SULFATES AND DEXAMETHASONE | 3 | 0.0148 |
| 3 | DIPHENHYDRAMINE HYDROCHLORIDE AND ZINC ACETATE | 1 | 0.0132 |
| 4 | ESTRONE | 1 | 0.0093 |
| 5 | METEX | 3 | 0.0079 |
| 6 | MINERAL OIL, WHITE PETROLATUM | 2 | 0.0069 |
| 7 | LINCOMYCIN HYDROCHLORIDE | 2 | 0.0068 |
| 8 | ANHYDROUS CITRIC ACID, ASPIRIN, AND SODIUM BICARBONATE | 2 | 0.0061 |
| 9 | ARFORMOTEROL TARTRATE | 1 | 0.0042 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 265 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 200 |
| 2 | Tumor Necrosis Factor Blocker [EPC] | 126 |
| 3 | Thalidomide Analog [EPC] | 100 |
| 4 | Interleukin-4 Receptor alpha Antagonist [EPC] | 88 |
| 5 | Anti-IgE [EPC] | 86 |
| 6 | Vitamin C [EPC] | 78 |
| 7 | Proton Pump Inhibitor [EPC] | 75 |
| 8 | Benzodiazepine [EPC] | 66 |
| 9 | Vitamin B12 [EPC] | 65 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Aryl Hydrocarbon Receptor Agonist [EPC] | 4 | 0.0020 |
| 1 | CD4-directed Blocking Antibody [EPC] | 1 | 0.0019 |
| 2 | Gadolinium-based Contrast Agent [EPC] | 7 | 0.0014 |
| 3 | 4-Hydroxyphenyl-Pyruvate Dioxygenase Inhibitor [EPC] | 1 | 0.0012 |
| 4 | Pyrethroid [EPC] | 2 | 0.0011 |
| 5 | Anti-IgE [EPC] | 86 | 0.0010 |
| 6 | Semifluorinated Alkane [EPC] | 2 | 0.0009 |
| 7 | Dihydrofolate Reductase Inhibitor Antimalarial [EPC] | 1 | 0.0008 |
| 8 | Pyruvate Kinase Activator [EPC] | 1 | 0.0008 |
| 9 | Phenylalanine Metabolizing Enzyme [EPC] | 6 | 0.0007 |